Immunscape is a privately-held drug discovery company based in Stockholm, Sweden. Founded in 2016, Immunscape is focused on the development of immunotherapies for the treatment of cancer and autoimmune diseases. Immunscape has a team with a proven track record of success in bringing small molecules from discovery phase to the clinic.
Immunscape
Immunscape develops small molecules to treat immune diseases and harness the immune system to fight cancer.
